// App-Quantinova.ai

LB288 : Glunomab®: A Novel “Barrier-Protecting” Monoclonal Antibody Efficient in Mouse Models of EAE.

Researchers

Presenter

  • Richard Macrez

Principal Investigators

  • Cristina Ortega

  • Isabelle Bardou

  • Anupriya Mehra

  • Antoine Fournier

  • Benoit Haelewyn

  • Ms. Suzanne Van der Pol

  • Eric Maubert

  • Flavie Lesept

  • Arnaud Chevilley

  • Fernando De Castro

  • Helga De Vries

  • Denis Vivien

  • Diego Clemente

  • Fabian Docagne

Medical Centers

  • INSERM U1237, caen, France

  • Grupo de Grupo de Neurobiología del Desarrollo-GNDe, Toledo, Spain

  • Centre Universitaire de Ressources Biologiques, Université de Caen Basse-Normandie, Caen, France

  • Department of Molecular Cell Biology and Immunology, Amsterdam, New Zealand

  • INSERM U1237, caen, France

  • Department of Neuroscience, Physiology and Pharmacology, london, United Kingdom

  • Grupo de Neurobiología del Desarrollo-GNDe, Madrid, Spain

  • Department of Molecular Cell Biology and Immunology, Amsterdam, New Zealand

  • Grupo de Grupo de Neurobiología del Desarrollo-GNDe, Toledo, Spain

Locations

  • France

  • Spain

  • New Zealand

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved